OVID

Ovid Therapeutics Inc.

Price

$2.93

return (12m)

211.70%

p/e

-16.19

p/bv

2.66

DIVIDEND YIELD

0.00%

OVID price

Ovid Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OVID

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

25.21%

3 months

20.08%

1 year

211.70%

2 years

157.02%

5 years

-16.52%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OVID

Valuation

P/E

-16.19

Sector -4.38

Industry -4.38

P/BV

2.66

Sector 2.02

Industry 2.02

P/Revenue (PSR)

353.48

Sector -4.40

Industry -4.40

EV/EBITDA

-28.14

Sector -263.09

Industry -263.09

EV/EBIT

-28.11

Sector -702.90

Industry -702.90

P/EBITDA

-9.58

Sector -4.39

Industry -4.39

P/EBIT

-9.57

Sector -4.73

Industry -4.73

P/Total Assets

2.41

Sector 1.49

Industry 1.49

P/Net Current Assets

5.50

Sector -11.70

Industry -11.70

P/Working Capital

4.91

Sector -3.19

Industry -3.19

EPS

-0.18

Sector -2.14

Industry -2.14

BVPS

1.07

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-2,147.95%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-2,150.68%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-16.44%

Sector -65.14%

Industry -65.14%

ROA

-14.87%

Sector -65.53%

Industry -65.53%

ROIC

-71.04%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

12.39

Sector 2.90

Industry 2.90

Net Debt / EBITDA

7.48

Sector -6.07

Industry -6.07

Net Debt / EBIT

7.47

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.56

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.90

Sector 0.41

Industry 0.41

Liabilities/Assets

0.10

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-62.33%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals OVID

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OVID Ovid Therapeutics Inc.	$2.93	214.11%	0.00%	-16.19	2.66	-16.44%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OVID Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ovid Therapeutics

Ovid Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

12 years

Founded: 2014

2017

Time since IPO - 9 years

67

Employees

Ovid Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $558.50 million, with shareholders equity totaling $209.89 million.

The company employs approximately 67 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Ovid Therapeutics Inc. reported $1.58 million in revenue, generating net income of $-34.50 million.

Key financial metrics include a P/E ratio of -16.19, a price-to-book (P/B) ratio of 2.66, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OVID.

Market cap

$558.50 million

Net worth

$209.89 million

$209,890,000.00

Assets

$231.97 million

$231,970,000.00

Total Shares Outstanding

197.00 million

197,000,000

Average Daily Trading Volume

$2.46 million

$2,463,030.00

Sector

Health Care

Industry

Biotechnology

OVID

OVID revenue and profits

Financial Results OVID

DRAG THE FRAME TO SEE MORE DATA

OVID cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Ovid Therapeutics (OVID) today?

A cotação de Ovid Therapeutics (OVID) hoje está em US$ 2.93, com uma variação de 211.7% em relação ao último ano. A cotação de Ovid Therapeutics (OVID) iniciou o ano negociando na casa dos US$ 1.63 e hoje está em US$ 2.93. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Ovid Therapeutics (OVID) e dados de ações do Ibovespa e mercados internacionais.

Quando Ovid Therapeutics (OVID) paga dividendos?

Ovid Therapeutics (OVID) não distribuiu dividendos no último ano.

Is Ovid Therapeutics (OVID) a good investment?

Atualmente, Ovid Therapeutics (OVID) está cotada a US$ 2.93, com um P/L de -16.19, representando um desvio de -654% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 211.7 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 211.70%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Ovid Therapeutics (OVID) stock?

Investir em ações de Ovid Therapeutics (OVID) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Ovid Therapeutics (OVID) yield today?

A rentabilidade de Ovid Therapeutics (OVID) foi de 25.21% no último mês, 211.70% no último ano e -16.52% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Ovid Therapeutics (OVID) hoje, o investimento total seria de US$ 293.00, com base na cotação atual de US$ 2.93.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 913.28
Em 5 anos: US$ 244.60
Em 10 anos: US$ 293.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

OVID

Ovid Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment OVID

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING OVID WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Ovid Therapeutics

Ovid Therapeutics Inc.

United States

12 years

2017

67

PROFIT X PRICE OVID

Financial Results OVID

OVID cash flow

Asset, Revenue and Profit Growth - OVID

OVID balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions